Valuation: Pfizer Inc.

Market Cap 155B 134B 126B 115B 216B 14,881B 219B 1,481B 580B 7,443B 583B 570B 24,791B P/E 2026 *
17.1x
P/E 2027 * 13.3x
Enterprise Value 203B 175B 165B 150B 282B 19,431B 286B 1,933B 758B 9,718B 761B 745B 32,370B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 3.31x
Free-Float
59.05%
Yield 2026 *
6.32%
Yield 2027 * 6.37%
1 day+0.84%
1 week+2.37%
Current month+8.96%
1 month+8.78%
3 months+7.58%
6 months-0.44%
Current year+9.44%
1 week 26.41
Extreme 26.41
27.4
1 month 24.44
Extreme 24.4417
27.4
Current year 23.62
Extreme 23.62
28.74
1 year 23.58
Extreme 23.58
28.74
3 years 20.92
Extreme 20.915
37.19
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 55 16/08/2026
Compliance Officer 65 01/12/2013
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Date Insider Type Main position Quantity % Market Cap.
12/08/26 Buy

Chief Executive Officer

38,000 0.0007%
05/08/26 Sell

Controller/Auditor

-3,278 0.0001%
05/08/26 Buy

Director

39,231 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%+2.37%+8.70%-25.67% 153B
+3.60%+0.88%+75.59%+124.32% 1,055B
+3.33%+4.35%+53.82%+57.17% 632B
+3.43%+3.53%+25.34%+72.45% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+1.75%-0.24%+25.28%+40.46% 290B
+2.13%-0.32%+0.58%+10.77% 243B
+1.41%+2.65%+45.34%+62.43% 227B
+1.35%-3.53%-14.72%-52.63% 200B
+3.25%+5.65%+21.57%+89.04% 172B
Average +2.24%+0.02%+28.25%+41.98% 376.57B
Weighted average by Cap. +2.71%+0.20%+42.28%+64.59%

Financials

2026 *2027 *
Net sales 62.24B 53.76B 50.58B 45.97B 86.46B 5,963B 87.72B 593B 233B 2,982B 234B 229B 9,934B 59.84B 51.68B 48.63B 44.19B 83.12B 5,733B 84.34B 570B 224B 2,867B 225B 220B 9,551B
Net income 8.9B 7.69B 7.23B 6.57B 12.36B 853B 12.55B 84.84B 33.25B 427B 33.42B 32.69B 1,421B 11.08B 9.57B 9B 8.18B 15.39B 1,062B 15.62B 106B 41.39B 531B 41.6B 40.7B 1,769B
Net Debt 47.48B 41.01B 38.59B 35.07B 65.96B 4,550B 66.93B 453B 177B 2,275B 178B 174B 7,579B 42.88B 37.04B 34.85B 31.67B 59.57B 4,109B 60.44B 409B 160B 2,055B 161B 158B 6,845B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
18/08/26 $27.25 +1.41% 34,660,086
17/08/26 $26.87 +0.30% 29,261,200
14/08/26 $26.79 -0.04% 23,174,152
13/08/26 $26.80 +1.86% 35,355,834
12/08/26 $26.31 -1.16% 32,591,426
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
27.25USD
Average target price
28.61USD
Spread / Average Target
+4.98%

Quarterly revenue - Rate of surprise